NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biomimetic Innovations

Biomimetic Innovations

Private
ShannonHealthcare & Life Scienceshttps://pbcbiomed.com/

Last Round

VC Round

Jan 21, 2025

Est. Valuation

$69.76M

Total Funding Raised

$6.42M

Company Overview

Biomimetic Innovations is a medical device company that develops and commercializes OsStic™, a synthetic, injectable, bio-adhesive bone void filler.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology, Clinical Trials, 3D Printing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

biomaterialsmedical devicesorthopedicsCDMOcontract manufacturingbone void fillerregulatory consultingregenerative medicineinjectable bio-adhesiveMedTech commercializationbone graft substitutecontract development and manufacturing organizationcartilage repairnerve repairimplant coatingveterinary medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biomimetic Innovations Comparables

Compare Biomimetic Innovations with similar companies based on industry and business-model similarity.

Biomimetic Innovations comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RevBio, Inc.
80%
Noraker
78%
Amend Surgical
76%

Biomimetic Innovations Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 21, 2025
GrantMay 4, 2021

Key People

Founding team and executive leadership

Thomas A. Russell

Major Shareholder, Board Member, And Chief Medical Officer

Executive Team

Biomimetic Innovations Investors

Notable investors and investment history

Biomimetic Innovations investors
InvestorRounds
Disruptive Technologies Innovation FundGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 21, 2026

    Grew 41% QoQ, from 49 to 69 employees.

  • Jan 21, 2025

    $9M round led by Sanara Medtech Inc.

Biomimetic Innovations Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biomimetic Innovations Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biomimetic Innovations's valuation, stock price, and market status.

Firmographic Details

HeadquartersShannon
Employee Range75
Year Founded2020
Last FundingJan 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.